| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.420.169.176 $ | +262.986.729 $ | +384,4 % | 12 | 1.115.529.859 $ | +442.231.506 $ | +71,0 % | 8 | 667.973.612 $ | +116.083.148 $ | +59,5 % | 5 | ||||
| Natera, Inc. | NTRA | → 0 | Neutral | 310.040.497 $ | -45.113.148 $ | -12,7 % | 1 | 355.153.645 $ | +105.605.073 $ | +42,3 % | 1 | 249.548.572 $ | -12.355.731 $ | -4,7 % | 1 |
| Jazz Pharmaceuticals plc | JAZZ | → 0 | Neutral | 113.113.719 $ | -50.062.481 $ | -30,7 % | 1 | 163.176.200 $ | +85.568.670 $ | +110,3 % | 1 | 77.607.530 $ | +3.950.062 $ | +5,4 % | 1 |
| ASTRAZENECA PLC | AZN | → 0 | 89.938.434 $ | -60.122.031 $ | -40,1 % | 1 | 150.060.465 $ | +86.848.325 $ | +137,4 % | 1 | |||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 142.534.603 $ | +65.724.026 $ | +85,6 % | 1 | 76.810.577 $ | -43.807.039 $ | -36,3 % | 1 | 120.617.616 $ | +86.562.905 $ | +254,2 % | 1 |
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 112.402.097 $ | -29.085.405 $ | -20,6 % | 1 | 141.487.502 $ | +60.294.240 $ | +74,3 % | 1 | 81.193.262 $ | +15.366.928 $ | +23,3 % | 1 |
| GILEAD SCIENCES, INC. | GILD | → 0 | Stark | 139.006.632 $ | +22.558.984 $ | +19,4 % | 1 | ||||||||
| FINANCIAL COUNSELORS INC | → 0 | 134.116.500 $ | +94.036.500 $ | +234,6 % | 1 | ||||||||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 120.615.929 $ | +39.005.033 $ | +47,8 % | 1 | 81.610.896 $ | +81.610.896 $ | 1 | |||||
| INVESCO QQQ TRUST, SERIES 1 | QQQ | → 0 | 86.577.000 $ | +86.577.000 $ | 1 | ||||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 81.350.578 $ | +11.247.418 $ | +16,0 % | 1 | ||||||||
| ISHARES TR | → 0 | 80.203.750 $ | +33.283.500 $ | +70,9 % | 1 | ||||||||||
| Celcuity Inc. | CELC | → 0 | Schwach | 76.037.215 $ | +46.173.363 $ | +154,6 % | 1 | ||||||||
| VERTEX PHARMACEUTICALS INC / MA | VRTX | → 0 | Neutral | 74.620.336 $ | +28.455.771 $ | +61,6 % | 1 | ||||||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 73.238.854 $ | +71.322.954 $ | +3.722,7 % | 1 | ||||||||
| AbbVie Inc. | ABBV | → 0 | Neutral | 72.610.238 $ | +37.655.570 $ | +107,7 % | 1 | ||||||||
| 1.420.169.176 $ | +262.986.729 $ | +384,4 % | 12 | 1.115.529.859 $ | +442.231.506 $ | +71,0 % | 8 | 667.973.612 $ | +116.083.148 $ | +59,5 % | 5 | ||||